Effect of the dual endothelin receptor antagonist bosentan on untreatable skin ulcers in a patient with diabetes: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effect of the dual endothelin receptor antagonist bosentan on untreatable skin ulcers in a patient with diabetes: a case report ; volume:5 ; number:1 ; day:16 ; month:4 ; year:2011 ; pages:1-4 ; date:12.2011
Journal of medical case reports ; 5, Heft 1 (16.4.2011), 1-4, 12.2011
- Urheber
-
Álvarez Reyes, Fátima
- Beteiligte Personen und Organisationen
-
Luna Gómez, Cristina
Brito Suárez, Manuel
SpringerLink (Online service)
- DOI
-
10.1186/1752-1947-5-151
- URN
-
urn:nbn:de:1111-2016071018789
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Álvarez Reyes, Fátima
- Luna Gómez, Cristina
- Brito Suárez, Manuel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Aprocitentan, A Dual Endothelin Receptor Antagonist Under Development for the Treatment of Resistant Hypertension
Structural basis of antagonist selectivity in endothelin receptors
Effekt von Endothelin-1 und Endothelin-A-Rezeptor-Antagonist auf die Mikrozirkulation bei TNBS-Colitis
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Der duale Endothelin-Rezeptor-Antagonist Bosentan inhibiert die TNF-alpha-induzierte GM-CSF-Expression in humanen glatten Bronchialmuskelzellen
Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)—a multicentre randomised controlled trial protocol
Macitentan: entry-into-humans study with a new endothelin receptor antagonist
Single-dose pharmacokinetics, safety, and tolerability of the dual endothelin receptor antagonist aprocitentan in subjects with moderate hepatic impairment
Synthesis of a 5HT7/5HT2 Dual Antagonist
Endothelin receptor antagonist improves donor lung function in an ex vivo perfusion system
Synthesis of Dual Orexin Receptor Antagonist MK-6096
Aprocitentan, A Dual Endothelin Receptor Antagonist Under Development for the Treatment of Resistant Hypertension
Structural basis of antagonist selectivity in endothelin receptors
Effekt von Endothelin-1 und Endothelin-A-Rezeptor-Antagonist auf die Mikrozirkulation bei TNBS-Colitis
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Der duale Endothelin-Rezeptor-Antagonist Bosentan inhibiert die TNF-alpha-induzierte GM-CSF-Expression in humanen glatten Bronchialmuskelzellen
Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)—a multicentre randomised controlled trial protocol
Macitentan: entry-into-humans study with a new endothelin receptor antagonist
Single-dose pharmacokinetics, safety, and tolerability of the dual endothelin receptor antagonist aprocitentan in subjects with moderate hepatic impairment
Synthesis of a 5HT7/5HT2 Dual Antagonist
Endothelin receptor antagonist improves donor lung function in an ex vivo perfusion system
Synthesis of Dual Orexin Receptor Antagonist MK-6096
Aprocitentan, A Dual Endothelin Receptor Antagonist Under Development for the Treatment of Resistant Hypertension
Structural basis of antagonist selectivity in endothelin receptors
Effekt von Endothelin-1 und Endothelin-A-Rezeptor-Antagonist auf die Mikrozirkulation bei TNBS-Colitis
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Der duale Endothelin-Rezeptor-Antagonist Bosentan inhibiert die TNF-alpha-induzierte GM-CSF-Expression in humanen glatten Bronchialmuskelzellen
Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)—a multicentre randomised controlled trial protocol
Macitentan: entry-into-humans study with a new endothelin receptor antagonist
Single-dose pharmacokinetics, safety, and tolerability of the dual endothelin receptor antagonist aprocitentan in subjects with moderate hepatic impairment
Synthesis of a 5HT7/5HT2 Dual Antagonist
Endothelin receptor antagonist improves donor lung function in an ex vivo perfusion system